Correction to the FIELD study report

Lancet

Volumn 368, Issue 9545, 2006, Pages 1415-

  Keech, Anthony ^a   Simes, John ^a   Barter, Philip ^a   Best, James ^a   Scott, Russell ^a   Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DISEASE COURSE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MEDICAL RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; RISK REDUCTION;

EID: 33750022291     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69594-9     Document Type: Letter

References (1)

1. The FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861